Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.
Ting Yan ShiLibing XiangJian Qing ZhuJi-Hong LiuPing ZhangHua Ying WangYanling FengTao ZhuYingli ZhangAijun YuWei JiangXipeng WangYaping ZhuSufang WuYincheng TengJiejie ZhangRong JiangWei ZhangHuixun JiaRong Yu ZangPublished in: Journal of gynecologic oncology (2022)